Range
45.55 - 47.89
Vol / Avg.
336.2K/420.9K
Div / Yield
-
52 Wk
14.16 - 48.7
Mkt Cap
2.2B
Payout Ratio
-
Open
47.04
P/E
-
EPS
-0.48
Shares
47.4M
Outstanding
47.4M
Total Float
38M
Sector: Health Care.Industry: Biotechnology
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidate to address medical needs.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-05
REV
Q1 2021Est.ActualSurprise
EPS-0.570-0.540 0.0300
REV1.870M6.189M4.319M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
PTGXProtagonist Therapeutics0.43%2.2B

Protagonist Therapeutics Frequently Asked Questions

Q

How do I buy Protagonist Therapeutics (PTGX) stock?

A

You can purchase shares of Protagonist Therapeutics (NASDAQ: PTGX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Protagonist Therapeutics's (PTGX) competitors?

Q

What is the target price for Protagonist Therapeutics (PTGX) stock?

A

The latest price target for Protagonist Therapeutics (NASDAQ: PTGX) was reported by Northland Capital Markets on May 24, 2021. The analyst firm set a price target for 42.00 expecting PTGX to fall to within 12 months (a possible -10.68% downside). 7 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Protagonist Therapeutics (PTGX)?

A

The stock price for Protagonist Therapeutics (NASDAQ: PTGX) is $47.02 last updated Fri Jul 23 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Protagonist Therapeutics (PTGX) pay a dividend?

A

There are no upcoming dividends for Protagonist Therapeutics.

Q

When is Protagonist Therapeutics (NASDAQ:PTGX) reporting earnings?

A
Protagonist Therapeutics’s Q2 earnings are confirmed for after-market on August 5, 2021.
Q

Is Protagonist Therapeutics (PTGX) going to split?

A

There is no upcoming split for Protagonist Therapeutics.

Q

What sector and industry does Protagonist Therapeutics (PTGX) operate in?

A

Protagonist Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.